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Abstract The AMP-activated protein kinase (AMPK) is a
heterotrimeric protein composed of a catalytic K subunit and
two regulatory subunits, L and Q. The Q subunit is essential for
enzyme activity by virtue of its binding to the C-terminus of the
K subunit and appears to play some role in the determination of
AMP sensitivity. We demonstrate that a Q1R70Q mutation
causes a marked increase in AMPK activity and renders it
largely AMP-independent. This activation is associated with
increased phosphorylation of the K subunit activation loop T172.
These in vitro characteristics of AMPK are also reflected in
increased intracellular phosphorylation of one of its major
substrates, acetyl-CoA carboxylase. These data illustrate the
importance of the Q1 subunit in the regulation of AMPK and its
modulation by AMP. ß 2001 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
The AMP-activated protein kinase (AMPK) is a heterotri-
meric protein, composed of K, L and Q subunits, involved in
regulating several metabolic pathways in response to cellular
stress [1^4]. Under conditions of metabolic substrate limita-
tion, hypoxia, exercise and heat-shock, AMPK is activated
allosterically by rising cellular AMP and by phosphorylation
of the catalytic K subunit by one or more AMPK kinases
(AMPKKs) on Thr172, located in the ‘T-loop’ of the catalytic
domain [1^8]. The K subunit has little activity as a monomer,
but its activity increases dramatically following the binding of
the non-catalytic L and Q subunits to its C-terminus [9^11].
The L and Q subunits also contribute to the stability of the
K subunit [9]. At present two K (K1, K2), two L (L1, L2) and
three Q (Q1, Q2, Q3) isoforms have been identi¢ed with tissue-
speci¢c heterogeneity of heterotrimer content and subcellular
distribution [10,12^18]. In addition to regulation by phos-
phorylation of the K subunit, the L subunit is modi¢ed by
post-translational myristoylation and by multi-site phosphor-
ylation, which contribute both to enzyme activity and subcel-
lular localization [19,20].
The Q subunit is the mammalian homologue of the Snf4
protein (Snf4p) of Saccharomyces cerevisiae, which is critical
for the activity of the Snf1 protein kinase, a kinase central to
metabolic adaptation in yeast [21,22]. The Q subunit binds
both to the K and L subunits and appears to have some role
in AMP sensitivity of the heterotrimer [9,11,16]. Heterotrimer
reconstituted with di¡erent Q subunits is activated allosteri-
cally in vitro in a di¡erential pattern, dependent on the pres-
ence of Q1, Q2, or Q3, the latter giving the least degree of AMP
dependence [16]. The Q subunits are not post-translationally
modi¢ed, save for an N-terminal acetylation noted in Q1 [19].
Sequence analysis of the Q subunits has identi¢ed that each
isoform contains four tandem motifs termed cystathionine
L-synthase (CBS) domains, initially identi¢ed in the enzyme,
CBS [23]. CBS domains have been identi¢ed in other proteins
as well, including voltage-gated chloride channels and inosine-
5P-monophosphate dehydrogenase, but their function in any
of these proteins remains unknown. Two di¡erent mutations
within the CBS domains of human CBS gene (D444N and
V453E) cause the disease homocystinuria [24]. Recently, a
non-conservative substitution (R200Q) in the ¢rst CBS do-
main of the Hampshire pig PRKAG3 gene, the porcine ho-
mologue of Q3 subunit, was shown to result in a phenotype
associated with high glycogen content in skeletal muscle [25].
We noted that the equivalent of the R200 residue in the ¢rst
CBS domain of Q3 was preserved in all of the mammalian
Q isoforms. Since the Q1 subunit is the most widely expressed
Q subunit of AMPK (Q3 being largely restricted to skeletal
muscle), we have elected to explore the impact of a CBS
domain mutation in this protein. We have investigated this
mutation by transient transfection of cDNAs, exploring its
impact on AMPK heterotrimer assembly, enzyme activity,
K subunit phosphorylation and AMP dependence of the iso-
lated enzyme. We have also created cell lines stably expressing
a Q1 mutant to observe its e¡ect on cellular phenotype. These
data indicate that Q1 R70Q mutation causes a dramatic acti-
vation of the KLQ heterotrimer, with increased phosphoryla-
tion of its K subunit and substantial loss of AMP dependence,
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indicating an important role for the ¢rst CBS domain in the
function of the AMPK Q subunit.
2. Materials and methods
2.1. Site-directed mutagenesis
Generation of the R70Q mutant was performed using a Quik-
Change1 site-directed mutagenesis kit (Stratagene) as described by
the manufacturers. The complementary primers used to introduce
the mutation were: 5P-GGTGACTAACGGTGTACAAGCTGCCC-
CTTTATGGGATAG-3P and 5P-CTATCCCATAAAGGGGCAGC-
TTGTACACCGTTAGTCACC-3P, with the base change introduced
underlined. The template for mutagenesis was the plasmid pMT2-HA-
Q1 previously described containing the human Q1 isoform with a hem-
agglutinin (HA) tag generated at the 5P-terminus [5]. Following muta-
genesis a BglII cassette (439 bp) from the con¢rmed R70Q mutant
was used to replace the corresponding region in the original pMT2-
HA-Q1 construct. The cassette region bearing the mutation was com-
pletely sequenced by Taq DyeDeoxy terminator cycle sequencing us-
ing an Applied Biosystems Model 373A Sequencer.
2.2. Transient expression and analysis of AMPK in COS cells
COS7 cells were cultured and transfected with cDNAs using
FUGENE0 reagent, as in [5]. The AMPK subunits were expressed
in pEBG, pBK-CMV and pMT2 for the K1, L1 and Q1 subunits,
respectively, as described previously [5]. Cell lysis, glutathione-agarose
puri¢cation of expressed kinase heterotrimer, immunoblotting and
measurement of AMPK activity have likewise been previously de-
scribed [5]. Heterotrimer composition was assessed by immunoblot-
ting of individual subunits with antibodies speci¢c for each. The anti-
K antibody anti-K(2^20) was generated by immunization with a pep-
tide encompassing amino acids 2^20, common to both the K1 and K2
subunits. The anti-L antibody was raised against a bacterially ex-
pressed L1 protein. The anti-Q1 antibody was raised against a synthetic
peptide encoding residues 319^331 of the human Q1 subunit, while an
anti-HA antibody was used to probe for epitope-tagged Q1. The phos-
phorylation state on T172 of the K1 subunit was assessed by immu-
noblotting with an antibody speci¢c for a phosphorylated T172 epi-
tope.
2.3. Stable expression of AMPK Q1 subunits in pulmonary ¢broblasts
For stable expression, PS120 cells lacking the Na/H antiporter
(Na/H exchanger (NHE)) were transfected in 6-well plates, using
LipofectAMINE0 reagent [26]. Per well, we co-expressed 0.25 Wg of
pECE-NHE3 and either 1.75 Wg of pMT2-HA-Q1 wild-type (WT) or
HA-R70Q-Q1 or expressed 0.25 Wg of pECE-NHE3 alone to create a
control line. Two days after the transfection, the cells were exposed to
the ‘H-killing’ selection test that eliminates cells that did not express
a functional NHE [27]. Following two subsequent rounds of acid
selection, lysates of pools of acid-selected cells were screened by im-
munoblotting with anti-HA antibody to identify the expression of the
Q constructs. Having identi¢ed pools expressing the Q constructs, in-
dividual clonal lines were then isolated by limiting dilution. In the
experiments reported herein, we used one isolate of control cells
and two di¡erent clonal lines each of WT Q1 and R70Q mutant.
2.4. Characterization of stably expressing cell lines
The clonal lines of PS120 cells were characterized with respect to
AMPK activity and heterotrimer composition, the phosphorylation
state of the K1 subunit on T172, and the state of acetyl-CoA carbox-
ylase (ACC) phosphorylation of S79 (the site of regulatory phosphor-
ylation of ACC by AMPK [28]). Studies were done of each cell line in
basal medium (Dulbecco’s modi¢ed Eagle’s medium with 10% fetal
calf serum and penicillin/streptomycin), unless stated otherwise.
2.4.1. Measurement of isolated AMPK activity. The clonal PS120
lines were grown to con£uency on 100 mm dishes. The cells were lysed
in the presence of Triton X-100 lysis bu¡er, as described previously
[5], and immunoprecipitated in the presence of Protein A/G Plus aga-
rose (Santa Cruz) and either anti-K(2^20) or anti-HA antibody. Fol-
lowing adsorption, immunoprecipitates were washed and resuspended
in bu¡er A (20 mM Tris^HCl, pH 7.4, 50 mM NaCl, 50 mM NaF,
5 mM NaPPi, 1 mM dithiothreitol, 1 mM PMSF, 2 Wg/ml leupeptin,
25 Wg/ml soybean trypsin inhibitor, and 50 WM benzamidine). The
AMPK activity of resuspended immunoprecipitates was measured as
previously described [5]. To determine any e¡ects of residual AMP
binding to heterotrimer, immunoprecipitated AMPK heterotrimer was
incubated for 15 min at 30‡C in the presence of 5P-nucleotidase
(62 mU/ml) from Crotalusa atrox (Sigma). Following incubation,
the nucleotidase was removed from the immobilized heterotrimer by
washing several times in bu¡er A prior to resuspension and measure-
ment of AMPK activity in the presence or absence of 200 WM AMP.
2.4.2. Assessment of ACC and AMPK phosphorylation state. Clo-
nal lines expressing NHE, pMT2-HA-Q1 (and NHE) and pMT2-HA-
R70Q-Q1 (and NHE) were incubated in the presence of 1 mM 5-ami-
noimidazole-4-carboxamide-1-L-D-ribofuranoside (AICAR), or an
equivalent volume of water, for 2 h at 37‡C. Subsequently, the cells
were lysed for 2 min in bu¡er A containing 0.4 mg/ml digitonin.
Samples were precipitated with 0.54 volumes of saturated ammonium
sulfate for 60 min on ice and centrifuged for 30 min at 14 000 rpm.
The pellets were resuspended in bu¡er A and matched for protein
prior to immunoblotting with horseradish peroxidase (HRP)-conju-
gated streptavidin to detect ACC or an ACC phospho-Ser79 speci¢c
antibody. To compare ACC phosphorylation with AMPK activation,
the immunoblots were also probed with the anti-K(2^20) and the anti-
phospho-T172 antibodies.
2.5. Miscellaneous
Protein content of samples was determined using the BCA assay
(Pierce). Data are given as mean of n samples þ S.E.M., where n is the
number of samples analyzed in each investigation. Comparisons be-
tween means were done using Student’s t test for paired data using
MYSTAT0.
3. Results
3.1. The CBS domains of the AMPK Q isoforms
A R200Q mutation in PRKAG3 has been demonstrated to
be associated with increased skeletal muscle glycogen deposi-
tion [25]. This substitution is situated within the ¢rst of four
CBS domains, present in the Q subunit. To determine the
Fig. 1. Alignment of the CBS domains. Shown are the alignments of the CBS domains present in human CBS (GenBank1 accession number
NP_000062) and the four present in human AMPK Q1 (U42412), human AMPK Q2 (AJ249976), human AMPK Q3 (AJ249977) and yeast Snf4p
(M21760). The conserved arginine at position 70 in the AMPK Q1 subunit and the corresponding arginine residues in the Q2 and Q3 subunits
are shaded gray. Identities or conservative amino acid substitutions are shaded black.
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extent of conservation of this arginine residue, the CBS do-
mains present in the human CBS, in the three human Q iso-
forms and in the yeast Snf4p were aligned (Fig. 1). Like the
pig Q3 isoform, the human Q3 isoform also contains an Arg
residue at the same position. Similarly, both human Q1 and Q2
demonstrate conservation of an Arg at this position. In con-
trast, neither the human CBS nor Snf4p possesses an Arg at
this location. Interestingly, comparison of the human Q iso-
forms demonstrates that although the conserved Arg is only
present in CBS-1 of this alignment, there are also Arg residues
in juxta-positions in the remaining three CBS domains. In
both CBS-2 and CBS-4 an arginine is present at the +1 posi-
tion, whereas in CBS-3 an Arg is present at the 32 position in
all three human Q isoforms. Furthermore, a second Arg is
present at the 33 position in both Q2 and Q3. Similarly,
Snf4p has conserved Arg residues at the +1, 32 and +1 posi-
tions for CBS domains 2, 3 and 4, respectively. Although the
occurrence of these additional conserved Arg residues implies
that they too may play a critical role in protein function, the
aim of this study was to focus on the conserved Arg in the
CBS-1 domain, given the observations in the Hampshire pig.
We elected to study the Q1 isoform, the Q isoform with the
widest tissue expression, to assess the impact of an RCQ
mutation within the CBS-1 domain (R70Q) on AMPK activ-
ity.
3.2. R70Q Q1-containing AMPK heterotrimer expressed in
COS cells
In COS7 cells, we transiently expressed by triple transfec-
tion of cDNAs AMPK heterotrimers containing AMPK K1
and L1 and either WT Q1 or R70Q Q1. Heterotrimers were
then isolated to homogeneity by glutathione adsorption chro-
matography for analysis. As shown by immunoblotting anal-
ysis, the R70Q Q1 mutation had no apparent impact on the
total of expressed enzyme or on the composition of the
AMPK heterotrimer obtained with equivalent amounts of K,
L and Q in each (Fig. 2A). Measurement of AMPK activity in
the presence and absence of AMP revealed two major changes
associated with the R70Q Q1-containing heterotrimer (Fig.
2B). First, the mutant was activated 5^9-fold when compared
to the WT heterotrimer. Second, the mutant had markedly
reduced AMP dependence; the WT enzyme basal activity in
the absence of AMP is 45% of the total measured in the
presence of AMP, while the mutant enzyme’s AMP-independ-
ent activity rises to 77% of the total.
Since the phosphorylation of T172 on the K subunit is re-
quired for enzyme activity [5^8], we postulated that a higher
fraction of the R70Q Q1-containing heterotrimers were phos-
phorylated on this residue. This prediction was con¢rmed on
immunoblotting of the isolated heterotrimers with an anti-
body speci¢c for the T172p epitope (Fig. 3). As determined
by the analysis of several such isolates, there is a greater than
8-fold increase in the phosphorylation of R70Q Q1-containing
heterotrimers at T172. Taken together, these data indicate
that R70Q Q1 mutation allows the accumulation of active
AMPK enzyme under conditions where there is much less
activation of the WT enzyme.
Fig. 2. Characterization of the R70Q Q1 mutation on AMPK het-
erotrimer expressed in COS7 cells. COS7 cells were co-transfected
with vectors encoding either pMT2-HA-Q1 WT or R70Q mutant
with pEBG-K1 and pBK-CMV-L1 with FUGENE0 reagent as de-
scribed in Section 2. Cells were harvested at 48 h post-transfection
and glutathione adsorbates prepared from the lysates. In A, eluted
WT and R70Q-containing heterotrimeric proteins were analyzed by
immunoblot using anti-K (upper panel), anti-L (middle panel) or
anti-Q (lower panel) antibodies, as described in Section 2. In B, WT
and R70Q-containing heterotrimeric proteins eluted from gluta-
thione adsorbates were assayed in the absence (black bars) or in the
presence (open bars) of AMP (200 WM). Kinase activity of each
construct is expressed as pmol of 32P transferred to the SAMS pep-
tide/min, in the presence of equivalent amounts of heterotrimer.
Data presented as mean þ S.E.M. of n = 4 enzyme isolates. The
R70Q activity is statistically di¡erent from the WT activity at
P6 0.001 by a two-tailed t test.
Fig. 3. Increased phosphorylation of the AMPK K subunit at
Thr172 in R70Q Q1 heterotrimer. Inset: isolated WT (A) and R70Q
(B) Q1-containing heterotrimeric proteins were probed with phospho-
T172 speci¢c or anti-K antibodies (upper and lower panels, respec-
tively). Quantitation of the T172p immunoblot is represented as
mean T172 phosphorylation in arbitrary units ( þ S.E.M. of n = 4
isolates) corrected for K subunit content, as judged by densitometry
of the immunoblots. The level of phosphorylation of T172 in the
R70Q Q1-containing heterotrimers is statistically di¡erent from that
of WT at P6 0.001 by a two-tailed t test.
FEBS 25016 29-6-01
S.R. Hamilton et al./FEBS Letters 500 (2001) 163^168 165
3.3. Stable expression of R70Q Q1-containing AMPK
heterotrimer
To investigate the e¡ect of chronic expression of the R70Q
Q1, we generated clonal PS120 cell lines stably overexpressing
the WT or mutant (R70Q) Q1 subunits. As a control line, we
employed PS120 cells stably expressing the selection vector
pECE-NHE3. Immunoprecipitation of cell lysates with anti-
HA antibody was successful in capturing AMPK heterotrimer
containing K, L and HA-tagged Q1 (Fig. 4A). These data in-
dicate that the plasmid-expressed Q subunits can recombine
with endogenous L and K subunits and that the R70Q muta-
tion did not in£uence this association. Immunoblotting of cell
lysates with K isoform-speci¢c antibodies revealed only the K1
isoform in these cells (data not shown). Precipitation of
AMPK heterotrimers with anti-HA antibody con¢rms a 2.5-
fold stimulation of the activity of the R70Q Q1-containing
heterotrimers measured in the presence of AMP (Fig. 4B).
Furthermore, the R70Q Q1-containing heterotrimer displayed
30% of maximal activity in the absence of AMP, while the
WT Q1-containing heterotrimer was nearly inactive. Nearly
identical data were obtained on analysis of AMPK immuno-
precipitated with the anti-K(2^20) antibody. Comparison of
samples immunoprecipitated with anti-HA antibody and
that with anti-K(2^20) antibody did indicate that more activity
was isolated from both WT and mutant lines with the anti-
HA antibody. This di¡erence in the isolated activities may be
representative of the di¡ering a⁄nities of each antibody for
heterotrimer. Alternatively, this may suggest that there is
more AMPK activity present in these cell lines than is recov-
ered by the K1/K2 recognizing pan antibody or possibly inter-
ference of this K antibody with the activity of the catalytic K
subunit. The increased expression of AMP-independent activ-
ity of the R70Q Q1-containing heterotrimers does not appear
to be a function of tightly bound AMP persisting through the
immunoisolation. Treatment of immunoprecipitates with
5P-nucleotidase, a technique shown by others to diminish the
activity of isolated enzyme by hydrolysis of bound AMP [6],
had no e¡ect on this AMP-independent activity (data not
shown).
To determine if the increase in AMPK activity of the
stably expressing cell lines was due to increased phosphoryla-
tion of the K subunit at T172, as observed in the transiently
expressed AMPK, immunoblots were performed of cell ex-
tracts after incubation of cells in the presence or absence of
the AMPK activator, AICAR. AICAR, following its metab-
olism to ZMP, normally causes activation and phosphoryla-
tion of AMPK K on T172 [29,30]. Immunoblotting with anti-
Fig. 4. Stable expression and characterization of WT and R70Q Q1
subunit in a PS120 cell line. The vector pECE-NHE, conferring acid
resistance, was transfected into the lung ¢broblast PS120 cell line in
the presence or absence of pMT2-HA-Q1 or pMT2-HA-R70Q-Q1.
Following acid selection and cell subcloning as described in Section
2, con£uent cells were lysed and AMPK heterotrimer immunopreci-
pitated with anti-HA antibody prior to immunoblotting. In A,
AMPK subunits were blotted with anti-K, -L, -Q and -HA speci¢c
antibodies to con¢rm the association of transfected WT and mutant
Q subunit with the endogenous K and L subunits. In B, the WT Q1,
R70Q Q1 and control PS120 stable cell lines were grown to 90%
con£uency in 6-well plates. Cells were lysed and AMPK hetero-
trimer immunoprecipitated from equal amounts of lysate protein
with either anti-K(2^20) antibody (open bars) or an anti-HA speci¢c
antibody (black bars). AMPK activity was assayed in the presence
(+) or in the absence (3) of 200 WM AMP. Kinase activity of each
construct is expressed as pmol of 32P transferred to the SAMS pep-
tide/min. Data presented as mean þ S.E.M. of n = 3 experiments.
The activity in the R70Q Q1-containing heterotrimers in all instances
is signi¢cantly di¡erent from the WT values at P6 0.005 by two-
tailed t test.
Fig. 5. Stimulation of stable cell lines demonstrating basal activation
of the R70Q heterotrimer. WT Q1, R70Q Q1 and control (NHE)
PS120 stable cell lines were grown to 90% con£uency in 6-well
plates. Cells were treated in the absence (3) or presence (+) of
1 mM AICAR for 2 h prior to digitonin lysis and ammonium sul-
fate precipitation. In this representative experiment, resuspended
protein was immunoblotted and the membranes were probed with
anti-AMPK K(2^20) (upper panel), anti-AMPK phospho-T172 (sec-
ond panel), HRP-conjugated streptavidin (to detect total ACC)
(third panel) and anti-ACC phospho-Ser79 (fourth panel) speci¢c
antibodies.
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K(2^20) antibody demonstrates, as expected, a shift in the
mobility of the K subunits in NHE control line and the WT
Q1-expressing lines following AICAR treatment (Fig. 5, upper
panel). To con¢rm that phosphorylation of T172 was, in part,
responsible for the mobility shift, extracts were also blotted
with the phospho-T172 speci¢c antibody, which con¢rmed
this AICAR-stimulated phosphorylation (Fig. 5, second pan-
el). As can be seen in Fig. 5 (the two upper most panels), the
overexpression of R70Q Q1 results in an K subunit that is
already phosphorylated with a small shift in gel mobility in
the absence of AICAR stimulation. The addition of AICAR
causes an increase in the gel shift and increased phosphoryla-
tion of a second slower migrating band, perhaps suggesting
another site of AICAR-stimulated phosphorylation causing
additional charge heterogeneity.
To determine if the stimulated AMPK activities seen in the
lysates and immunoprecipitates derived from the overexpress-
ing R70Q Q1 cells were re£ective of heightened intracellular
activity, cell extracts were examined for the state of ACC
phosphorylation, as one of the major targets of AMPK. Over-
expression of either WT or R70Q Q1 in PS120 cells had no
e¡ect on overall ACC expression, as determined by streptav-
idin^HRP blotting (Fig. 5, panel three). Immunoblotting with
ACC isoform-speci¢c antibodies reveals that only ACC-K is
expressed in these cells (data not shown). Blotting of extracts
with an antibody directed against the major regulatory phos-
phorylation site for AMPK (Ser79p) on ACC showed no
phosphorylation of ACC in basal cells, but an increase in
ACC Ser79 phosphorylation in response to AICAR in control
and WT Q cell lines (Fig. 5, lower panel), mirroring the ob-
served changes in AMPK Thr172 phosphorylation/activation.
In extracts derived from the overexpressing R70Q Q1 cells,
ACC is already phosphorylated at Ser79 with a small increase
on the addition of AICAR, consistent with the increase in
basal AMPK activity seen in immunoprecipitates and the
heightened T172 phosphorylation of the K subunit in extracts.
Immunolocalization of the PS120 cells expressing WT Q1
and R70Q Q1 demonstrated no signi¢cant di¡erence in the
cellular distribution of either the HA-tagged Q1 subunits or
of endogenous K subunits (K1 and K2) (data not shown). In
these cell lines, the predominant expression of both Q and K
subunits is largely nuclear, but with a substantial amount of
extranuclear localization as well. Electron microscopy of the
control NHE, WT Q1 and R70Q Q1-expressing cell lines did
not indicate any ultrastructural di¡erences between them
(data not shown).
In preliminary studies, we have begun to examine other
features of the cellular phenotype of PS120 cells, a pulmonary
¢broblast line. The overexpression of WT or R70Q Q1 in these
cells has no e¡ect on the rate of glycogen synthesis, glucose
transport (in the presence or absence of cytochalasin B) or on
cell proliferation (data not shown).
4. Discussion
The present investigation characterizes the functional con-
sequence of an Arg to Gln substitution within the ¢rst CBS
domain of the human AMPK Q1 subunit. The basis of this
mutation derives from a report on a homologous mutation in
the AMPK Q3 isoform isolated from pig skeletal muscle [25].
Sequence analysis of the three human Q isoforms indicates that
this Arg residue is conserved at an equivalent position in CBS-
1 of each protein, prompting our investigation. The Q3 iso-
form is rather restricted in its tissue expression. Northern blot
analysis has demonstrated a predominance in skeletal muscle,
while immunoprecipitation with anti-Q3 antibody showed
AMPK activity primarily in the brain and testis [16]. In con-
trast, both Q1 and Q2 are widely expressed, with Q1 being
present in most tissues.
Our results demonstrate that the R70Q Q1 mutation results
in an increase in AMPK activity during acute and chronic
expression. Under acute conditions, we observed a 5^9-fold
increase in activity, while chronic expression demonstrated a
2^3-fold increase in activity. In both models, there was a
striking increase in the activity of AMPK in the absence of
AMP. Furthermore, in both instances, the increase in activity
was paralleled by a concurrent increase in basal phosphoryla-
tion of the AMPK K subunit at the site of activating phos-
phorylation by AMPKK(s) [5^8]. The impact of the Q3 sub-
unit mutation at the equivalent position seemed to indicate a
decrease in AMPK activity, as measured in crude muscle ex-
tracts, though the authors speculated that, in fact, there had
been an initial increase in kinase activity resulting in glycogen
accumulation, followed by inhibition of kinase activity subse-
quent to this fuel storage [25]. Our study does not clarify the
impact of the Hampshire pig mutation on the phenotype ob-
served in the pig skeletal muscle, as we have studied a di¡er-
ent Q subunit and, in the cells employed, have observed no
changes in glucose transport or glycogen synthesis.
The mechanism by which the mutation in Q1 activates
AMPK activity cannot be totally clari¢ed from the present
study, but some features are notable. The mutant heterotrimer
appears to have increased AMP-independent activity in both
model systems studied. The binding site for AMP on the
enzyme heterotrimer has not been identi¢ed and, other than
the catalytic ATP binding site on the K subunit, there are no
characteristic adenylate binding sites on any of the individual
subunits, suggesting that higher order structure contributed to
by all three subunits underlies AMP stimulation. The Q sub-
unit has been shown to in£uence the degree of AMP stimu-
lation of the reconstituted heterotrimer with the Q3-containing
heterotrimer showing the least degree of AMP stimulation
[16]. Perhaps a structural change as a result of the Q mutations
mimics structurally the interactions of AMP with sequences
on the Q isoform, causing AMP-like activation. We have noted
that the mutation is associated with heightened phosphoryla-
tion of the activation loop T172 on the K subunit. The phos-
phorylation of this residue by upstream AMPKKs has been
shown to be stimulated and its dephosphorylation by protein
phosphatases inhibited by binding of AMP to the hetero-
trimer [6,7]. It is tempting to speculate that the Q1 mutation,
by being ‘AMP-mimetic’, causes a similar change in the reac-
tivity of the heterotrimer with AMPKK(s) or protein phos-
phatases, resulting in increased phosphorylation and activa-
tion of the heterotrimer. Alternatively, it is possible that the
degree of antecedent T172 phosphorylation in£uences the in-
teraction of the heterotrimer with AMP.
The activating e¡ect of the Q1 mutation is not just observed
in vitro with measured AMPK activity, but also in intact cells.
ACC is one of the major substrates for AMPK and is phos-
phorylated on Ser79 (and other residues) in response to
AMPK [28]. In our experiments, we were able to document
the ability of AICAR to stimulate phosphorylation of ACC
Ser79 in control (NHE) and WT Q1-overexpressing cells,
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although in the basal state, no ACC phosphorylation at this
site was detectable. In contrast, ACC Ser79 is already nearly
maximally phosphorylated in the absence of AICAR in R70Q
Q1-overexpressing cells, consistent with maximal AMP-inde-
pendent activity within the cell. AICAR, which activates the
enzyme after its conversion to ZMP, an AMP-mimetic nucle-
otide, has only a small additional e¡ect on ACC phosphory-
lation, consistent with the AMP-independent nature of the
activation of the intracellular enzyme.
The position of the Arg to Gln mutations in CBS-1 of the
AMPK Q subunits is equivalent to the reported D444N muta-
tion in the CBS domain of CBS [24]. This latter mutation has
no e¡ect on basal catalytic activity, but does abolish the acti-
vation of CBS by S-adenosylmethionine. Taken together,
these data suggest that the CBS domain may play a regulatory
role for both AMPK and CBS by in£uencing interactions with
adenosine derivatives. An attempt to clarify if AMP was in-
teracting directly with the CBS domain of the AMPK Q sub-
unit has been addressed [16]. This study, using two di¡erent
adenosine derivatives, was unable to show speci¢c binding to
the Q subunit alone, but did show that saturating concentra-
tions of AMP did have a protective e¡ect against the binding
of 8-azido-[32P]AMP. Therefore, the exact role of the CBS
domain remains elusive, but the present study con¢rms the
importance of the residues at equivalent positions to Arg70
of AMPK Q1 in this and other CBS domain-containing pro-
teins.
Note added in proof
After acceptance of this manuscript, Gollob and co-workers
reported that an autosomal dominant R302Q mutation in the
¢rst CBS domain of the Q2 subunit (a position equivalent to
R70 in Q1) is responsible for familial Wol¡-Parkinson-White
syndrome, the second most common cause of cardiac parox-
ysmal supraventicular tachycardia (New England Journal of
Medicine, 344, 1823^1831, 2001). While the author’s do not
report the e¡ects of the R302Q mutation on enzyme activity,
it seems likely, based on our investigation, that enhanced
AMPK activity is responsible for the developmental and func-
tional defects in cardiac conduction in this syndrome.
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